3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Gallbladder Neoplasms: new trials by email Literature Review of Gallbladder Neoplasms trials Research Report on Gallbladder Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Addition of Everolimus to Standard of Care in Carcinoma Gallbladder Everolimus 10 mg, Standard of care - Gallbladder Cancer | Phase 2 / Phase 3 | Unknown | Banaras Hindu University | 56 | 2022-11-01 | 2024-08-13 |
| Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection Gemcitabine, Capecitabine - Cholangiocarcinoma, Gall Bladder Carcinoma | Phase 3 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 460 | 2018-12-15 | 2018-12-19 |
| Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma Concurrent Chemoradiotherapy, capecitabine, gemcitabine - Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct | Phase 3 | Unknown | Fudan University | 140 | 2016-04-01 | 2016-06-22 |
Biliary Tract Diseases (3) · Biliary Tract Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gallbladder Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2)
Capecitabine (2) · Gemcitabine (2) · Chemoradiotherapy (1) · Drug Therapy (1) · Everolimus (1) · Standard of Care (1)
Banaras Hindu University (1) · Fudan University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (2) · India (1)